Toth Financial Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100
Closed -$11K 690
2021
Q1
$11K Sell
100
-100
-50% -$10.7K ﹤0.01% 455
2020
Q4
$22K Hold
200
﹤0.01% 325
2020
Q3
$18K Hold
200
﹤0.01% 323
2020
Q2
$20K Buy
200
+100
+100% +$8.8K ﹤0.01% 282
2020
Q1
$8K Hold
100
﹤0.01% 289
2019
Q4
$9K Buy
+100
New +$8.3K ﹤0.01% 309

Other funds holding ABBV

Toth Financial Advisory's ABBV Position: Q2 2026 in Review

Toth Financial Advisory increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $366K and bringing the position to 59,705 shares worth $15M. The position accounts for 1.47% of the portfolio, ranked #15.

Toth Financial Advisory first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,064 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Toth Financial Advisory held 59,705 shares of AbbVie worth $15M as of Q2 2026.
  • Toth Financial Advisory bought 1,702 AbbVie shares in Q2 2026, an estimated $366K.
  • AbbVie made up 1.47% of Toth Financial Advisory's portfolio in Q2 2026, its #15 holding.
  • Toth Financial Advisory first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,064 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.